Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
58.78 USD | -0.12% | -5.82% | -20.55% |
Apr. 17 | Exact Sciences Corporation announced that it has received $266.75 million in funding | CI |
Apr. 15 | Sector Update: Health Care Stocks Advance Premarket Monday | MT |
Financials (USD)
Sales 2024 * | 2.83B | Sales 2025 * | 3.23B | Capitalization | 10.81B |
---|---|---|---|---|---|
Net income 2024 * | -161M | Net income 2025 * | 6M | EV / Sales 2024 * | 4.35 x |
Net Debt 2024 * | 1.5B | Net Debt 2025 * | 1.08B | EV / Sales 2025 * | 3.69 x |
P/E ratio 2024 * |
-67
x | P/E ratio 2025 * |
2,254
x | Employees | 6,550 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.02% |
Latest transcript on Exact Sciences Corporation
1 day | -0.12% | ||
1 week | -5.82% | ||
Current month | -14.89% | ||
1 month | -14.89% | ||
3 months | -12.08% | ||
6 months | -1.57% | ||
Current year | -20.55% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Conroy
CEO | Chief Executive Officer | 58 | 09-03-17 |
Paul Limburg
CTO | Chief Tech/Sci/R&D Officer | - | 18-03-05 |
Jorge Garces
CTO | Chief Tech/Sci/R&D Officer | 52 | 21-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
D. Coward
BRD | Director/Board Member | 59 | 14-12-31 |
Kevin Conroy
CEO | Chief Executive Officer | 58 | 09-03-17 |
Freda Lewis-Hall
BRD | Director/Board Member | 69 | 20-04-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
6.80% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 58.78 | -0.12% | 2,216,577 |
24-04-26 | 58.85 | +0.10% | 2,019,062 |
24-04-25 | 58.79 | -7.04% | 2,648,606 |
24-04-24 | 63.24 | -0.46% | 1,213,600 |
24-04-23 | 63.53 | +1.79% | 1,777,688 |
Delayed Quote Nasdaq, April 29, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.55% | 10.81B | |
+47.97% | 3.36B | |
-32.75% | 2.22B | |
-14.15% | 2.16B | |
-26.06% | 1.55B | |
+19.85% | 1.04B | |
-2.62% | 746M | |
-31.67% | 425M | |
-43.88% | 405M | |
+29.03% | 378M |
- Stock Market
- Equities
- EXAS Stock